BRAIN Biotech AG
XETRA:BNN
ROCE
Return on Capital Employed
ROCE, or Return on Capital Employed, is a financial ratio that measures a company’s profitability in relation to the capital it employs.
ROCE Across Competitors
ROCE Comparison
BRAIN Biotech AG Competitors
Country | DE |
Market Cap | 71.9m EUR |
ROCE |
-11%
|
Country | JP |
Market Cap | 12.7T JPY |
ROCE |
17%
|
Country | US |
Market Cap | 78.9B USD |
ROCE |
22%
|
Country | US |
Market Cap | 62.6B USD |
ROCE |
12%
|
Country | CH |
Market Cap | 41.6B CHF |
ROCE |
16%
|
Country | CH |
Market Cap | 35.9B CHF |
ROCE |
12%
|
Country | CN |
Market Cap | 273.4B CNY |
ROCE |
17%
|
Country | IN |
Market Cap | 2.7T INR |
ROCE |
40%
|
Country | US |
Market Cap | 31.7B USD |
ROCE |
14%
|
Country | US |
Market Cap | 31.4B USD |
ROCE |
5%
|
Country | CH |
Market Cap | 27B EUR |
ROCE |
-2%
|
Profitability Report
View the profitability report to see the full profitability analysis for BRAIN Biotech AG.
See Also
ROCE, or Return on Capital Employed, is a financial ratio that measures a company’s profitability in relation to the capital it employs.
Based on BRAIN Biotech AG's most recent financial statements, the company has ROCE of -10.5%.